tiprankstipranks
Advertisement
Advertisement

BIIB Stock Latest News

Biogen Shareholders Back Board, Auditor and Pay Policies
Company AnnouncementsBiogen Shareholders Back Board, Auditor and Pay Policies
13h ago
8K
BIIB
Needham upgrades Biogen on pipeline potential, stabilizing core business
PremiumThe Fly
Needham upgrades Biogen on pipeline potential, stabilizing core business
3d ago
BIIB
Biogen upgraded to Buy from Hold at Needham
PremiumThe Fly
Biogen upgraded to Buy from Hold at Needham
3d ago
BIIB
Biogen Advances BIIB115 in Post–Gene Therapy SMA: Early Signals for Long‑Term Growth
PremiumCompany Announcements
Biogen Advances BIIB115 in Post–Gene Therapy SMA: Early Signals for Long‑Term Growth
6d ago
BIIB
Biogen granted Breakthrough Therapy Designation for salanersen by FDA
PremiumThe Fly
Biogen granted Breakthrough Therapy Designation for salanersen by FDA
7d ago
BIIB
UCB, Biogen announce dapirolizumab pegol data at EULAR
PremiumThe FlyUCB, Biogen announce dapirolizumab pegol data at EULAR
7d ago
BIIB
Biogen, UCB publishes full results from PHOENYCS GO clinical trial in The Lancet
Premium
The Fly
Biogen, UCB publishes full results from PHOENYCS GO clinical trial in The Lancet
10d ago
BIIB
Biogen and Denali’s BIIB122 Parkinson’s Trial Completion Sets Up Key Catalyst for Investors
Premium
Company Announcements
Biogen and Denali’s BIIB122 Parkinson’s Trial Completion Sets Up Key Catalyst for Investors
13d ago
BIIB
DNLI
Biogen price target raised to $227 from $222 at RBC Capital
PremiumThe Fly
Biogen price target raised to $227 from $222 at RBC Capital
15d ago
BIIB
Biogen and Denali’s Parkinson’s candidate did not meet Phase 2b endpoints
PremiumThe Fly
Biogen and Denali’s Parkinson’s candidate did not meet Phase 2b endpoints
21d ago
BIIB
DNLI
Biogen Earnings Call Signals Confident, Investment-Heavy Transition
PremiumCompany Announcements
Biogen Earnings Call Signals Confident, Investment-Heavy Transition
22d ago
BIIB
Immunic appoints Michael Bonney as chair
PremiumThe Fly
Immunic appoints Michael Bonney as chair
23d ago
BIIB
IMUX
Goldman’s Richter Reiterates Buy on Biogen as Leqembi Outperforms and Price Target Rises from $238 to $250
PremiumRatingsGoldman’s Richter Reiterates Buy on Biogen as Leqembi Outperforms and Price Target Rises from $238 to $250
27d ago
BIIB
Biogen: Hold Rating Reiterated as Pipeline Concerns Offset Leqembi Growth; $196 Price Target Maintained
Premium
Ratings
Biogen: Hold Rating Reiterated as Pipeline Concerns Offset Leqembi Growth; $196 Price Target Maintained
27d ago
BIIB
Cisco upgraded, Doximity downgraded: Wall Street’s top analyst calls
Premium
The Fly
Cisco upgraded, Doximity downgraded: Wall Street’s top analyst calls
27d ago
AOS
PHR
Biogen resumed with an Outperform at Evercore ISI
PremiumThe Fly
Biogen resumed with an Outperform at Evercore ISI
27d ago
BIIB
Biogen price target raised to $225 from $214 at Piper Sandler
PremiumThe Fly
Biogen price target raised to $225 from $214 at Piper Sandler
27d ago
BIIB
Hold Rating Maintained on Biogen as BIIB080 Moves to Phase 3; Risk-Reward Seen Balanced with Unchanged $206 Price Target
PremiumRatings
Hold Rating Maintained on Biogen as BIIB080 Moves to Phase 3; Risk-Reward Seen Balanced with Unchanged $206 Price Target
27d ago
BIIB
Biogen Buy Rating Reiterated as Tau Data Eases Overhang; Price Target Maintained at $225
PremiumRatings
Biogen Buy Rating Reiterated as Tau Data Eases Overhang; Price Target Maintained at $225
27d ago
BIIB
Biogen Rated Hold as Analyst Cites Mixed Alzheimer’s Data and Commercial Hurdles; $203 Price Target Reiterated
PremiumRatingsBiogen Rated Hold as Analyst Cites Mixed Alzheimer’s Data and Commercial Hurdles; $203 Price Target Reiterated
27d ago
BIIB
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
Premium
The Fly
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
28d ago
DYN
ALEC
Biogen Buy Rating Reiterated as CELIA Phase 2 Diranersen Data De-Risk Tau Strategy and Support Unchanged $237 Price Target
Premium
Ratings
Biogen Buy Rating Reiterated as CELIA Phase 2 Diranersen Data De-Risk Tau Strategy and Support Unchanged $237 Price Target
28d ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >